Hypertension in the elderly

Michael Maddens1, Khaled Imam, Ayham Ashkar

  • 1Division of Geriatric Medicine, William Beaumont Hospital, 3535 West 13 Mile Road, Suite 108, Royal Oak, MI 48073, USA. mmaddens@beaumont.edu

Primary Care
|September 6, 2005
PubMed

Insights

Treating hypertension in elderly patients can reduce adverse cardiovascular events, but benefits in the very elderly are unclear, with potential risks to overall mortality. Careful blood pressure targets are crucial to avoid negative cognitive effects.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Clinical Pharmacology

Background:

  • Hypertension is a significant risk factor for adverse events in elderly individuals.
  • The benefits and risks of hypertension treatment in the very elderly (over 80) require careful consideration.
  • Current guidelines for target blood pressures in older adults remain a subject of debate.

Purpose of the Study:

  • To review the evidence regarding hypertension treatment in the elderly.
  • To discuss the complexities of blood pressure targets and potential risks in very elderly patients.
  • To evaluate the role of lifestyle modifications and pharmacological interventions.

Main Methods:

  • Literature review of studies on hypertension management in elderly populations.
  • Analysis of data concerning cardiovascular outcomes, overall mortality, and cognitive function.
  • Evaluation of treatment strategies including lifestyle changes and pharmacotherapy.

Main Results:

  • Hypertension treatment reduces cardiovascular events in the elderly up to age 80.
  • In the very elderly, treatment may decrease cardiovascular events but potentially increase overall mortality.
  • Lowering systolic blood pressure (SBP) below 159 mm Hg is beneficial, but caution is advised if diastolic blood pressure (DBP) falls below 65 mm Hg or the day-night BP difference exceeds 20%.
  • Aggressive SBP reduction below 135 mm Hg may accelerate cognitive decline.

Conclusions:

  • While hypertension treatment offers benefits for cardiovascular outcomes in the elderly, the impact on overall mortality in the very elderly is less clear.
  • Individualized blood pressure targets are essential, considering potential risks like cognitive decline and increased mortality.
  • Lifestyle modifications (sodium restriction, exercise, weight loss) and judicious use of first-line agents like thiazides are recommended, with careful monitoring for side effects.

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.